Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B
100%
Diphtheria
59%
Tetanus
59%
Haemophilus Influenzae Type B
40%
Pertussis
40%
Diseases
37%
Hepatitis B Virus
26%
Hepatitis B Antigen
26%
Enzyme-Linked Immunosorbent Assay
25%
Prevalence
24%
Cross-Sectional Study
18%
Salmonella Enterica Serovar Typhi
18%
Typhoid Fever
18%
Hepatitis B Core Antibody
15%
Infection
14%
Hepatitis B Vaccine
9%
Weakness
9%
Infection Rate
9%
Immunogenicity
9%
Combination Vaccine
7%
Measles Vaccine
5%
Immunology and Microbiology
Hepatitis B
48%
Prevalence
47%
Seroprevalence
37%
Norovirus
37%
Hepatitis B Virus
32%
Haemophilus Influenzae Type B
23%
Haemophilus influenzae
23%
Serotype
23%
Hepatitis B Vaccination
23%
Measles
18%
HBsAg
18%
Rubella antibody
18%
Measles Antibody
18%
Monoclonal Antibody
18%
Hepatitis B Antigen
18%
Salmonella enterica serovar typhi
18%
Hepatitis B Core Antibody
15%
ELISA
14%
Rubella
11%
X Ray
10%
Capsid
10%
Antiserum
9%
Cross-Reactivity
9%
Measles Vaccine
9%
Binding Antibody
7%
Seropositivity
7%
Antibody Titer
6%
Virus
5%
Keyphrases
Seroprotection
37%
Haemophilus Influenzae
18%
Routine Vaccination
18%
Influenza B
18%
Hepatitis B
18%
Tetanus
18%
CdtB
18%
Salmonella Typhi (S. Typhi)
18%
Diphtheria
18%
Multiple Indicator Cluster Survey
18%
GII.17
18%
Structural Evolution
18%
Human Norovirus (HuNoV)
18%
Whole Cell
18%
Diphtheria-tetanus-pertussis
18%
Typhoid Fever
15%
Health Centers
14%
Hospital Level
12%
Hepatitis B Infection
12%
Hepatitis B Antigens
12%
Combination Vaccine
12%
HlyE
11%
Pentavalent Vaccine
9%
Vaccine Response
9%
Hyle
7%
Repeat Donors
7%
HBV Markers
6%
Past Infection
6%
Older Students
6%
Adult Population
6%
Hepatitis B Birth Dose
6%
Ethnolinguistic Groups
6%
Infectious Disease Surveillance
6%
Research Building
6%
Expanded Access
6%
Regional Economics
6%
Hmong-Mien
6%
Minority Groups
6%
GII.4 Variant
6%
Paratyphi
5%
Community Control
5%
Salmonella Paratyphi
5%